Industry Insight
Information, Observation & Analysis
With millions of people dying annually worldwide from pneumonia, the facts about who is at risk of contracting this disease and how it can be prevented have never been more important.
From identifying the strain to prioritizing high-risk recipients, a look at lessons learned from the development and distribution of the H1N1 vaccine.
Vaccines to treat pre-existing conditions have the potential to radically change medical treatment, and there’s renewed hope that therapeutic vaccines might soon be available to treat various diseases.
The search for a preventive and therapeutic vaccine for HIV has long been studied. A look at past and current research shows just how far we’ve come.
Scientists are working on a variety of molecular and imaging diagnostics to advance the early detection rate of cancer.
A behind-the-scenes look at what goes into a successful flu immunization clinic, whether it’s large or small.
New options in immune globulin therapy give patients more options for receiving this gold-standard treatment.
Providers hoping to counteract the anti-vaccine movement can cultivate trust by setting aside time for vaccine discussions and using effective, empathetic communication to encourage vaccine compliance.
Rabies is a viral infection that is easily preventable, but almost always fatal if not treated.
A look at the extraordinary safety record of the plasma industry's continuous supply of safe therapies at volume.
During the past three decades,IVIG has proven an effective treatment for a wide range of autoimmune diseases, and it is now believed that IVIG may have clinical uses for a broader range of medical conditions.
The current H1N1 pandemic exemplifies the need for more expeditious production of flu vaccine, and two companies have placed this technology just within reach.